Catalyst Wire Dossier Catalyst Wire Dossier

Anti-IL-23 inhibitors

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Anti-IL-23 inhibitors, covering 2025-05-25 to 2025-05-25. Get the full timeline:

Most recent: Clinical Trial Update: Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors [NA]

See pricing